Xarelto Bleeding Lawsuit | Xarelto Side Effects : Bleeding, Blood Clots | Xarelto Lawsuit

Xarelto Bleeding Lawsuit | Xarelto Side Effects : Bleeding, Blood Clots | Xarelto Bleeding lawsuits

Xarelto bleeding lawsuit, Xarelto Side Effects, Xarelto Bleeding, Xarelto Blood Clots, Xarelto Bleeding lawsuits, Xarelto lawsuits, Xarelto Pulmonary Embolism, Internal Bleeding, Deep Vein Thrombosis, Hemorrhaging, Brain Bleeding, Gastrointestinal Bleeding

xarelto-bleeding-lawsuit-side-effects-bleeding-blood-clots-xarelto-lawsuit-rivaroxabanXarelto bleeding lawsuit News: Xarelto is a blood thinner used to reduce the risks of stroke and blood clots in individuals suffering from atrial fibrillation (irregular heart beats) also known as A-Fib, that are not a result of heart valve problems. Xarelto reduces the chances of a stroke by preventing blood clots from forming and traveling to the brain or other parts of the body, which may cause a stroke or embolism, or block arteries. Xarelto is similar to other well-known blood-thinning medication such as Coumadin (warfarin) and Pradaxa (dabigatran etexilate).

Side effects such as bleeding complications and hemorrhaging have been reported by individuals who take the prescription medication. When giving its initial approval for Xarelto in November 2011, the U.S. Food & Drug Administration (FDA) issued a black box warning stating that patients with atrial fibrillation run a risk of having a heart attack and stroke when suddenly discontinuing the medication.

Wright & Schulte LLC is investigating possible Xarelto bleeding lawsuits. If you or a loved one have taken Xarelto and experienced blood clots, heart attack, stroke or death, you may be eligible to file your own Xarelto bleeding lawsuit complaint. Contact Wright & Schulte LLC today for a free lawsuit evaluation at 1-800-403-6191.

The law firm is now offering free Xarelto bleeding side effects lawsuit legal evaluations to anyone who may have suffered from life-threatening internal bleeding and related complications while using Xarelto, including:

  • Gastrointestinal Bleeding
  • Cerebral Bleeding / Hemorrhage
  • Body injury Bleeding / Hemorrhaging
  • Heart Attack
  • Stroke
  • Blood Clots
  • Death

Xarelto bleeding lawsuits Due To Severe Bleeding, Blood clots

xarelto-bleeding-lawsuit-rivaroxabanCourt records indicate a Xarelto bleeding lawsuit was filed in February against Johnson & Johnson and Bayer AG on behalf of a Kentucky woman who allegedly experienced internal bleeding after using the blood thinner. The complaint purports that the Kentucky woman was prescribed Xarelto in July 2012 to treat atrial fibrillation, and was hospitalized six months later with severe internal and gastrointestinal bleeding. The Xarelto bleeding lawsuit contends that Johnson & Johnson should not have sold the medication and should have known Xarelto was associated with “irreversible bleeds.” The Xarelto bleeding lawsuit was filed in the Pennsylvania Court of Common Pleas, Philadelphia County. (Stuntebeck v. Janssen Research & Development LLC et al, Case Number 140201754)

Reuters reported that the Germany-based Bayer AG is facing its first Xarelto bleeding lawsuits in the U.S. over Xarelto. Additionally, Xarelto is Bayer’s top-selling medication, having made $1.3 billion in sales in 2013.
[reuters.com/article/2014/06/14/us-bayer-suit-idUSKBN0EP0HW20140614, June 14, 2014]

Xarelto Side Effects Include severe bleeding…

xarelto-bleeding-lawsuit-side-effects-bleeding-blood-clots-rivaroxaban.jpgXarelto can cause serious bleeding because it is a blood-thinning medication that reduces blood clotting, according to the Xarelto website. People taking Xarelto may be easily bruised and it may take longer for bleeding to stop. According to the U.S. Institutes of Health, there is no known antidote for coagulants such as rivaroxaban (Xarelto), dabigatran (Praxdaxa) or apixaban (Eliquis) nor is there any specific treatment with proven effectiveness for handling severe bleeding linked to these drugs.

Other side effects of the drug include:

  • Vomiting blood or vomit that looks like “coffee grounds”
  • Red, pink or brown urine
  • Bright red or black stools
  • Nose bleeds that happen often
  • Coughing up blood or blood clots
  • Headaches, dizziness, weakness
  • Pain, swelling, or new drainage at wound sites.

Xarelto FDA Black Box Warnings

FDA-LogoThe FDA issued its most serious warning, called a “black box warning,” that those who abruptly stop taking Xarelto without replacing it with another blood thinner are at an increased risk of stroke. The FDA also warned that epidural or spinal hematomas (a mass of clotted blood that forms in a tissue, organ or other spaces in the body due to a broken blood vessel) occurred in patients taking Xarelto who were receiving anesthesia or undergoing spinal puncture. The hematomas could result in long-term or permanent paralysis.
[fda.gov/safety/medwatch/safetyinformation/ucm367392.htm, March, 2014]
[accessdata.fda.gov/drugsatfda_docs/label/2011/202439s001lbl.pdf, December 2011]
[fda.gov/downloads/Drugs/DrugSafety/UCM280333.pdf]
[ncbi.nlm.nih.gov/pubmed/23866358, June 22, 2013]

What is Xarelto?

Xarelto, generically known as rivaroxaban, is an oral anticoagulant drug that prevents blood clots from forming. The blood thinner is also used to treat potentially life-threatening conditions including deep vein thrombosis, which occurs when blood clots form in veins deep within the body, usually in the legs. The drug is also used to treat pulmonary embolism, when blood clots in the lungs and stops blood from flowing. It is also given to patients who have just had hip or knee replacement surgery to reduce the risk of blood clots in the legs and lungs.

Bayer manufactures Xarelto and Janssen Pharmaceutica, a division of Johnson & Johnson, markets the product in the United States, according to Xarelto’s website.

The drug was initially approved by the FDA in November 2011 for use in patients with irregular heart beat and then in November 2012 for use in patients with deep vein thrombosis and pulmonary embolism.
[fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm, November 2, 2012]

Xarelto New England Journal of Medicine Study

A clinical study was published in the September issue of the New England Journal of Medicine on Xarelto. A double-blind trial, called ROCKET AF, used 14,264 patients with atrial fibrillation who were at increased risk of stroke. These patients took either a daily dose of 20 mg of rivaroxaban or a dose-adjusted warfarin blood thinner. The study concluded that patients who took Xarelto had a reduced risk of problems with bleeding in the brain compared to patients who took warfarin. The study also concluded that rivaroxaban, or Xarelto, was shown to be just as effective for preventing stroke or systemic embolism as warfarin.
[nejm.org/doi/full/10.1056/NEJMoa1009638#t=article, September 8, 2011]

About Wright & Schulte LLC And Filing An Xarelto bleeding lawsuit

Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today for a FREE Xarelto bleeding lawsuit evalution through yourlegalhelp.com or by calling 1-800-399-0795.

Print